• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“这是一扇脆弱的敞开的门”-提高接受物质使用障碍治疗人群的 COVID-19 疫苗接种率。

'It's a fragile open door'-enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder.

机构信息

Drug and Alcohol Services, Northern Sydney Local Health District, St Leonards, New South Wales, Australia.

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

出版信息

J Public Health (Oxf). 2023 Nov 29;45(4):e729-e736. doi: 10.1093/pubmed/fdad181.

DOI:10.1093/pubmed/fdad181
PMID:37709530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10687600/
Abstract

BACKGROUND

People with substance use disorder are at high risk of harms from COVID-19 infection. Vaccine hesitancy is common in this population and compounds pre-existing barriers to accessing health care. A drug and alcohol service in Sydney, Australia introduced strategies to enhance COVID-19 vaccination in people receiving opioid agonist treatment (OAT). We report vaccination outcomes and staff experiences of this.

METHODS

This mixed methods study (i) retrospectively evaluated vaccine uptake in people accessing OAT and (ii) explored perceptions of staff who delivered vaccination interventions through surveys and semi-structured interviews.

RESULTS

Of the 984 patients receiving OAT on 9 December 2021, 90.9% had received the first COVID-19 vaccination and 86.7% the second. Australia wide vaccination rates on that date were 93.1% and 88.7% for first and second doses, respectively. Staff commented that having a deep knowledge, understanding and connection with the patient group drove implementation and success of vaccination interventions. This was further supported by staff engagement with the vaccination interventions, and communication and sharing information, both between staff and with patients.

CONCLUSION

High rates of COVID-19 vaccination can be achieved in a vulnerable population. Engaged staff providing information and facilitating access to healthcare underpin this success.

摘要

背景

患有物质使用障碍的人感染 COVID-19 的风险很高。该人群普遍存在疫苗犹豫情绪,这加剧了他们原本就难以获得医疗保健的问题。澳大利亚悉尼的一家毒品和酒精服务机构引入了策略,以提高接受阿片类激动剂治疗(OAT)的人群的 COVID-19 疫苗接种率。我们报告了这项工作的疫苗接种结果和工作人员的经验。

方法

这项混合方法研究(i)回顾性评估了接受 OAT 的人群的疫苗接种率,(ii)通过调查和半结构化访谈探索了提供疫苗接种干预的工作人员的看法。

结果

在 2021 年 12 月 9 日接受 OAT 的 984 名患者中,90.9%已接种第一剂 COVID-19 疫苗,86.7%已接种第二剂。在该日期,澳大利亚全国第一剂和第二剂疫苗接种率分别为 93.1%和 88.7%。工作人员评论说,对患者群体有深入的了解、理解和联系,推动了疫苗接种干预措施的实施和成功。工作人员对疫苗接种干预措施的参与、以及工作人员之间和与患者之间的沟通和信息共享,进一步支持了这一点。

结论

在弱势群体中可以实现高 COVID-19 疫苗接种率。积极参与提供信息和促进获得医疗保健的工作人员是成功的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c3c/10687600/6c10f9d8a785/fdad181f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c3c/10687600/6c10f9d8a785/fdad181f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c3c/10687600/6c10f9d8a785/fdad181f1.jpg

相似文献

1
'It's a fragile open door'-enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder.“这是一扇脆弱的敞开的门”-提高接受物质使用障碍治疗人群的 COVID-19 疫苗接种率。
J Public Health (Oxf). 2023 Nov 29;45(4):e729-e736. doi: 10.1093/pubmed/fdad181.
2
Optimizing Access to the COVID-19 Vaccination for People Experiencing Homelessness.优化为无家可归者提供 COVID-19 疫苗接种的途径。
Int J Environ Res Public Health. 2022 Nov 25;19(23):15686. doi: 10.3390/ijerph192315686.
3
Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis.实施教育:与医疗保健专业人员进行个人交流是解决多发性硬化症患者疫苗犹豫问题的关键步骤。
Mult Scler Relat Disord. 2022 Jul;63:103933. doi: 10.1016/j.msard.2022.103933. Epub 2022 Jun 1.
4
Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study.在加拿大,识别药物使用者对 COVID-19 疫苗接种的障碍和促进因素:一项全国性定性研究。
Harm Reduct J. 2023 Jul 29;20(1):99. doi: 10.1186/s12954-023-00826-6.
5
Uptake of COVID-19 vaccination among community-dwelling individuals receiving healthcare for substance use disorder and major mental illness: a matched retrospective cohort study.社区居住的接受物质使用障碍和主要精神疾病医疗服务人群的 COVID-19 疫苗接种率:一项匹配的回顾性队列研究。
Front Public Health. 2024 Jul 5;12:1426152. doi: 10.3389/fpubh.2024.1426152. eCollection 2024.
6
COVID-19 vaccine implementation at a syringe services program: experiences of frontline staff.在注射服务项目中实施 COVID-19 疫苗:一线工作人员的经验。
BMC Health Serv Res. 2024 Oct 19;24(1):1260. doi: 10.1186/s12913-024-11691-9.
7
Self-Reported COVID-19 Vaccine and Booster Acceptance and Hesitancy Among Autistic Adults in Pennsylvania: Cross-Sectional Analysis of Survey Data.宾夕法尼亚州自闭症成年人自我报告的新冠疫苗及加强针接种接受度与犹豫情况:调查数据的横断面分析
JMIR Public Health Surveill. 2024 Aug 28;10:e51054. doi: 10.2196/51054.
8
Addressing vaccine hesitancy and resistance for COVID-19 vaccines.应对 COVID-19 疫苗的犹豫和抵制。
Int J Nurs Stud. 2022 Jul;131:104241. doi: 10.1016/j.ijnurstu.2022.104241. Epub 2022 Apr 1.
9
Factors influencing staff attitudes to COVID-19 vaccination in care homes in England: a qualitative study.影响英国养老院工作人员对 COVID-19 疫苗接种态度的因素:一项定性研究。
BMC Health Serv Res. 2023 Oct 6;23(1):1066. doi: 10.1186/s12913-023-10031-7.
10
Exploring COVID-19 vaccine uptake and hesitancy among vulnerable populations in inner city Vancouver, Canada: Insights into characteristics and clinical outcomes.探讨加拿大温哥华内城区弱势群体对 COVID-19 疫苗的接种和犹豫情况:特征和临床结局的相关见解。
Vaccine. 2024 Sep 17;42(22):125904. doi: 10.1016/j.vaccine.2024.04.050. Epub 2024 Apr 17.

引用本文的文献

1
Suspicion and other feelings about COVID-19 vaccines and mask-wearing among individuals recovering from substance addiction.物质成瘾康复者对新冠疫苗和佩戴口罩的怀疑及其他感受。
Public Health Pract (Oxf). 2025 Feb 15;9:100599. doi: 10.1016/j.puhip.2025.100599. eCollection 2025 Jun.

本文引用的文献

1
One-year results from the vaccination campaign against COVID-19 infection in 47 million individuals with severe mental disorders and other chronic diseases.接种疫苗预防 COVID-19 感染:4700 万严重精神障碍和其他慢性疾病患者的一年结果。
Eur Arch Psychiatry Clin Neurosci. 2023 Mar;273(2):517-521. doi: 10.1007/s00406-022-01467-9. Epub 2022 Aug 15.
2
COVID-19 Vaccination Status and Concerns Among People Who Use Drugs in Oregon.俄勒冈州使用毒品人群的 COVID-19 疫苗接种状况和担忧。
J Addict Med. 2022;16(6):695-701. doi: 10.1097/ADM.0000000000001002. Epub 2022 Jul 8.
3
COVID-19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona, Spain.
西班牙巴塞罗那的阿片类药物使用障碍者的 COVID-19 疫苗接种率和疫苗犹豫情况。
Drug Alcohol Rev. 2022 Sep;41(6):1311-1318. doi: 10.1111/dar.13502. Epub 2022 Jun 6.
4
Uptake of COVID-19 vaccination among people who inject drugs.注射毒品人群中 COVID-19 疫苗的接种情况。
Harm Reduct J. 2022 Jun 3;19(1):59. doi: 10.1186/s12954-022-00643-3.
5
How Vaccine Ambivalence Can Lead People Who Inject Drugs to Decline COVID-19 Vaccination and Ways This Can Be Addressed: Qualitative Study.疫苗矛盾心理如何导致注射吸毒者拒绝接种新冠疫苗以及应对方法:定性研究
JMIR Form Res. 2022 Mar 23;6(3):e35066. doi: 10.2196/35066.
6
COVID-19 vaccine acceptability among people in Australia who inject drugs: Update from the 2021 Illicit Drug Reporting System interviews.澳大利亚注射吸毒人群对 COVID-19 疫苗的接受度:2021 年非法药物报告系统访谈的最新情况。
Drug Alcohol Rev. 2022 Jul;41(5):1025-1028. doi: 10.1111/dar.13448. Epub 2022 Feb 20.
7
COVID-19 vaccine acceptability among people in Australia who inject drugs: Implications for vaccine rollout.澳大利亚注射毒品人群对 COVID-19 疫苗的接受程度:对疫苗推广的影响。
Drug Alcohol Rev. 2022 Feb;41(2):484-487. doi: 10.1111/dar.13399. Epub 2021 Nov 9.
8
Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.辅助针具交换项目客户接受丙型肝炎治疗的障碍及干预机会。
Int J Drug Policy. 2021 Oct;96:103387. doi: 10.1016/j.drugpo.2021.103387. Epub 2021 Jul 28.
9
Vaccinating Australia: How long will it take?接种疫苗:需要多长时间?
Vaccine. 2022 Apr 14;40(17):2491-2497. doi: 10.1016/j.vaccine.2021.07.006. Epub 2021 Jul 17.
10
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries.新冠病毒疫苗在中低收入国家的接受程度和犹豫。
Nat Med. 2021 Aug;27(8):1385-1394. doi: 10.1038/s41591-021-01454-y. Epub 2021 Jul 16.